-
Something wrong with this record ?
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer
A. Maestre, J. Trujillo-Santos, A. Visoná, JL. Lobo, E. Grau, R. Malý, R. Duce, M. Monreal, . ,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Anticoagulants therapeutic use MeSH
- Fibrin Fibrinogen Degradation Products analysis metabolism MeSH
- Humans MeSH
- Neoplasms blood MeSH
- Pulmonary Embolism blood MeSH
- Prognosis MeSH
- Risk Factors MeSH
- Aged MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The prognostic value of D-dimer testing in patients with acute pulmonary embolism (PE) has not been thoroughly studied. METHODS: We used the RIETE Registry data to assess the 90-day prognostic value of increased IL Test D-dimer levels at baseline in patients with PE, according to the presence or absence of cancer. RESULTS: As of May 2013, 3,283 patients with acute PE underwent D-dimer testing using IL Test D-dimer. Among 2,588 patients without cancer, those with D-dimer levels in the highest quartile had a higher rate of fatal PE (2.6% vs. 0.9%; p=0.002), fatal bleeding (1.1% vs. 0.3%; p=0.017) and all-cause death (9.1% vs. 4.4%; p<0.001) at 90 days compared with those with levels in the lowest quartiles. Among 695 patients with cancer, those with levels in the highest quartile had a similar rate of fatal PE or fatal bleeding but higher mortality (35% vs. 24%; p<0.01). On multivariate analysis, non-cancer patients with D-dimer levels in the highest quartile had an increased risk for fatal PE (odds ratio [OR]: 3.3; 95% CI: 1.6-6.6), fatal bleeding (OR: 4.3; 95% CI: 1.4-13.7) and all-cause death (OR: 2.1; 95% CI: 1.4-3.1) compared with patients with levels in the lowest quartiles. CONCLUSIONS: Non-cancer patients with acute PE and IL Test D-dimer levels in the highest quartile had an independently higher risk for fatal PE, fatal bleeding and all-cause death at 90 days than those with levels in the lowest quartiles. In patients with cancer, D-dimer levels failed to predict fatal PE or fatal bleeding.
Department of Haematology Hospital Lluís Alcanyís Xàtiva Spain
Department of Internal Medicine Hospital Universitari Germans Trias i Pujol Badalona Barcelona Spain
Department of Internal Medicine Hospital Vinalopó Salud Elche Alicante Spain
Department of Pneumonology Hospital de Txagorritxu Alava Vitoria Spain
Internal Medicine Thrombosis Center Ospedale Galliera Genoa Italy
Vascular Medicine Ospedale Castel Franco TV Castelfranco Veneto Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008397
- 003
- CZ-PrNML
- 005
- 20150401101058.0
- 007
- ta
- 008
- 150306s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.thromres.2013.12.044 $2 doi
- 035 __
- $a (PubMed)24438941
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Maestre, Ana $u Department of Internal Medicine, Hospital Vinalopó Salud, Elche, Alicante, Spain.
- 245 10
- $a D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer / $c A. Maestre, J. Trujillo-Santos, A. Visoná, JL. Lobo, E. Grau, R. Malý, R. Duce, M. Monreal, . ,
- 520 9_
- $a BACKGROUND: The prognostic value of D-dimer testing in patients with acute pulmonary embolism (PE) has not been thoroughly studied. METHODS: We used the RIETE Registry data to assess the 90-day prognostic value of increased IL Test D-dimer levels at baseline in patients with PE, according to the presence or absence of cancer. RESULTS: As of May 2013, 3,283 patients with acute PE underwent D-dimer testing using IL Test D-dimer. Among 2,588 patients without cancer, those with D-dimer levels in the highest quartile had a higher rate of fatal PE (2.6% vs. 0.9%; p=0.002), fatal bleeding (1.1% vs. 0.3%; p=0.017) and all-cause death (9.1% vs. 4.4%; p<0.001) at 90 days compared with those with levels in the lowest quartiles. Among 695 patients with cancer, those with levels in the highest quartile had a similar rate of fatal PE or fatal bleeding but higher mortality (35% vs. 24%; p<0.01). On multivariate analysis, non-cancer patients with D-dimer levels in the highest quartile had an increased risk for fatal PE (odds ratio [OR]: 3.3; 95% CI: 1.6-6.6), fatal bleeding (OR: 4.3; 95% CI: 1.4-13.7) and all-cause death (OR: 2.1; 95% CI: 1.4-3.1) compared with patients with levels in the lowest quartiles. CONCLUSIONS: Non-cancer patients with acute PE and IL Test D-dimer levels in the highest quartile had an independently higher risk for fatal PE, fatal bleeding and all-cause death at 90 days than those with levels in the lowest quartiles. In patients with cancer, D-dimer levels failed to predict fatal PE or fatal bleeding.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antikoagulancia $x terapeutické užití $7 D000925
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibrin-fibrinogen - produkty degradace $x analýza $x metabolismus $7 D005338
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádory $x krev $7 D009369
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a plicní embolie $x krev $7 D011655
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Trujillo-Santos, Javier $u Department of Internal Medicine, Complejo Hospitalario Universitario de Cartagena, Cartagena, Murcia, Spain.
- 700 1_
- $a Visoná, Adriana $u Vascular Medicine, Ospedale Castel Franco TV, Castelfranco Veneto (TV), Italy.
- 700 1_
- $a Lobo, José Luís $u Department of Pneumonology, Hospital de Txagorritxu, Alava, Vitoria, Spain.
- 700 1_
- $a Grau, Enric $u Department of Haematology, Hospital Lluís Alcanyís, Xàtiva, Spain.
- 700 1_
- $a Malý, Radovan $u Department of Cardiovascular Medicine I, Charles University in Prague, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové, Czech Republic.
- 700 1_
- $a Duce, Rita $u Internal Medicine, Thrombosis Center, Ospedale Galliera, Genoa, Italy.
- 700 1_
- $a Monreal, Manuel $u Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain. Electronic address: mmonreal.germanstrias@gencat.cat.
- 700 1_
- $a ,
- 773 0_
- $w MED00004518 $t Thrombosis research $x 1879-2472 $g Roč. 133, č. 3 (2014), s. 384-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24438941 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150401101328 $b ABA008
- 999 __
- $a ok $b bmc $g 1065670 $s 891197
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 133 $c 3 $d 384-9 $i 1879-2472 $m Thrombosis research $n Thromb Res $x MED00004518
- LZP __
- $a Pubmed-20150306
